- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jan Berger Wishes AJMC Another 20 Years
Jan Berger, MD, MJ, wishes The American Journal of Managed Care a happy 20th anniversary and looks forward to another 20 years, plus she looks forward to the 20th anniversary of sister publication The American Journal of Pharmacy Benefits, of which Dr Berger is the editor-in-chief.
Jan Berger, MD, MJ, wishes The American Journal of Managed Care a happy 20th anniversary and looks forward to another 20 years, plus she looks forward to the 20th anniversary of sister publication The American Journal of Pharmacy Benefits, of which Dr Berger is the editor-in-chief.
How has The American Journal of Managed Care impacted the field of managed care over the last 20 years?
The American Journal of Managed Care has had a really unique position in the world of managed care in the last 20 years. And that is that the publication combines peer-reviewed, thoughtful science that actual impacts very real-world situations. That's very rare in an academic world, in a policy world, or in a practice world. That's actually why I read the journal every month when it comes in.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
